Trial intelligence / Profile preview

TXA and Blood Coagulation in Total Hip Arthroplasty

NCT03897621Completed

Sponsor
Thomas Jefferson University
Start
May 2019
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in hemorrhage, sponsored by Thomas Jefferson University. Primary endpoint: Fibrinolysis. Started May 2019; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT03897621.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03897621.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call